NVAX surged an impressive 29.4% last trading day with significant volume. Net positive volume increased massively from 6.33M to 28.12M for a 344% increase. These extraordinary numbers should be telling of what's to come in the mid to long term.
Buyers are back in the scene, positioning at the current price range in anticipation of growth prospect both in...
1) RSI 2 moving averages will cross each other soon. Purple one 38.14 and Green one 38.69. If purple one cut above green one it will be buy sign. I am waiting for buying next year because this is monthly chart. I hope RSI's 2 moving averages will cross each other. 36.91, 35.21 and 31.72 were very important support line in the past and it reversed from this...
Seems like 3.5 is a string demand area that pushes the price very hard to the upside. The last time was in Jan 2020. I don't think is going to explode above 30 but the next resistance is at 10. This is a high volatile stock, I bought calls exp 04/19 strike 5.5. If this breaks out will be massive.
Novavax is, besides a big pharma stock and one of the main previous providers of COV!D vaccines, a cyclical stock.
It has been for 20 years, and I'm betting 2% of my portfolio it is going to be again.
Despite the latest earnings, we are in the midst of the early part of the global liquidity cycle, which doesn't mean up-only, but Novavax is likely to be only...
Novavax (NVAX) - signs of potential breakout 4-hour
Novavax is a clinical-stage biotechnology company developing a vaccine for influenza. The company's stock has been undervalued for some time, but it is starting to show signs of a breakout. The stock is up over 40% in the past month, and it is trading above its 50-day and 200-day moving averages.
...
In a quest to reclaim lost ground and assert its presence in the competitive COVID-19 vaccine market, Novavax (NASDAQ: NASDAQ:NVAX ) charts a strategic course aimed at improving commercial performance and gaining market share from industry giants Pfizer (PFE.N) and Moderna (MRNA.O).
Despite facing headwinds and a larger-than-expected fourth-quarter loss, Novavax...
NVAX Technical Analysis
NVAX has been showing some solid bullishness since settling the Gavi dispute. NVAX is pumping out of the buy zone, and there has been a bullish breakout above the light blue resistance line. The key price target ahead is the green resistance line ($6.36), a yellow resistance zone ($8.20 to $8.46), and a red resistance line ($10.23). I have...
Today NVAX is selling for a tiny fraction of its all-time high as shown in a previous idea. Earnings
is coming this upcoming week. This week NVAX news release showed it had settled a years long
litigation over a failed COVID. In the face of earnings around the corner, was this news release
a coincidence or instead a case of excellent executive and legal...
NVAX on a 120 minute chart demonstrates a trend down in the past month after a period of
consolidation producing the POC line on the volume profile. The MACD shows some bullish
divergence. The volume profile has high volume nodes at 4.0 and 5.0 separated by a relative
volume void. NVAX fell quickly through that void. It can just as easily rise through it....
NVAX on the 15 minute chart has been compressing price action volatility into a symmetrical
triangle. It in now in a breakout of the triangle and in the process when from undervalued on
Monday to the upper trendline and then down to the support trendline and then up again.
It passed through the volume profile and its high volume area. In short, it has bullish...
NRIX , on the 15 minute chart is experiencing increase volatility and volume now two
days out from its earnings report. It printed a "big ass" green engulfing candle to finish the
week. The MACD with zero lag shows a bullish inflection in the lines
On the daily chart, price fell about 25% in 2023. earnings have been both line beats but
the negative cash flow...
NASDAQ:NVAX breaking out of base with strong volume after it announced that it reached settlement with Gavi Vaccine Allliance. The longer the base the strongerthe return.
Gather around the camp fire and lets forgive healthcare and biotech this year... and the last.
This year its different, I want to see the rotation in over valuing vaccine stocks again.
It looks to me like NVAX is completing a textbook Wyckoff Accumulation schematic. I believe the bottom is in and we've double-tapped the spring. Now it's time for the "wall of worry" as we head back up toward fib extensions. Just my humble opinion.
NVAX has been making lower lows since 1998, and price is currently falling towards the descending angle. (orange circles)
Will it touch it again? If price falls below $3 it will.
Looking at the big picture, every time NVAX touched this declining trend line, price went parabolic.
How high could price go?
Look at the purple channel. Price either peaked at the...
This is a split screen of NVAX, both on the weekly time frame.
The chart on the right is the bollinger bands. Currently there's a squeeze and the mouth is just beginning to open. Price is under the white basis line, and if the mouth of the bands begins to open wider, it's likely price will get dragged down and ride the bottom yellow band.
The chart on the left...
Hello investors, we are all looking for the chance to manage our money ourselves and make high profits. I would like to make my own contribution to this. Here is my trade from NOVAVAX. My idea invest 100 eur or usd and get almost 900% profit. Buying and holding is currently the best option. Basically, I advise everyone who follows my recommendations, but also...
